System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Fabrizio Pasanisi is an expert in Nutrition at Federico II University Hospital (Italy). As of March 2026, ScienceLeadR ranks Fabrizio Pasanisi in the top 1% of experts worldwide for Body Weight. Fabrizio Pasanisi has authored 296 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 855 (community average: 125). How the SLR is computed.

LeadR Profile

Fabrizio Pasanisi Federico II University Hospital Italy
855 ScienceLeadR Reputation 855

Unlock

Register Login
Network Map

Nutrition

Subspecialties: Oncology - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026
Source: PubMed

Federico II University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 296

Citations

Citations: 7 065 1st author: 19 Last author: 119 Unique author: 1

Main journals

Clin Nutr 53
Nutrition 22
Nutrients 16
Nutr Metab Cardiovasc Dis 15
Eat Weight Disord 13

Best Journals

Ann Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Higher intake of dietary dicarbonyl compounds is associated with lower incidence of type 2 diabetes: European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study.
PMID 41843191 — diabetes mellitus, incidence, neoplasms, cohort studies, diabetes mellitus, type 2		Eur J Nutr20260
Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer risk.
PMID 41637936 — biomedical research, neoplasms, metabolomics, fatty acids		EBioMedicine20260
SYNERGIES BETWEEN FOOD BIODIVERSITY, PROCESSING LEVELS, AND THE EAT-LANCET DIET FOR NUTRIENT ADEQUACY AND ENVIRONMENTAL SUSTAINABILITY: A MULTI-OBJECTIVE OPTIMIZATION USING THE EPIC COHORT.
PMID 41260521 — nutrients, multiple chronic conditions, diet, food, nutritional physiological phenomena, biodiversity, food, processed		Am J Clin Nutr20251
Antibody responses to 11 Fusobacterium proteins and colorectal cancer-specific and overall survival in the EPIC cohort.
PMID 41196234 — fusobacteria, antibody formation, mortality, blood, neoplasms, diagnosis, fusobacterium, colorectal neoplasms		Cancer Epidemiol Biomarkers Prev20250
Tracking Anxiety in Chronic Intestinal Failure: The Role of Time in Healing.
PMID 41095589 — parenteral nutrition, home, caregivers, psychotherapy, intestinal failure		Healthcare (Basel)20250

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 2 1

By status:

Completed 2
Unknown 2
Recruiting 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS IF) Without Colon in continuity (CIC)
NCT06904872 — short bowel syndrome, safety, powders, colon, double-blind method, solutions, malabsorption syndromes, therapeutics, gastrointestinal diseases, postoperative complications, intestinal failure		Phase 2Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS